Antimalarial drug toxicity: a review.

Antimalarial drug toxicity: a review.

Malaria, caused mostly by Plasmodium falciparum and P. vivax, remains one of the most important infectious diseases in the world. Antimalarial drug toxicity is one side of the risk-benefit equation and is viewed differently depending upon whether the clinical indication for drug administration is ma...

Descripció completa

Dades bibliogràfiques
Autors principals:	Taylor, W, White, N
Format:	Journal article
Idioma:	English
Publicat:	2004

Ítems similars

Toxicity of antimalarial drugs.
per: Peto, T
Publicat: (1989)

The cardiovascular toxicity of antimalarial drugs
per: Chan, XHS
Publicat: (2019)

Antimalarial drug resistance
per: White, N
Publicat: (2004)

Antimalarial drug resistance.
per: White, N
Publicat: (2004)

Cardiotoxicity of antimalarial drugs.
per: White, N
Publicat: (2007)

The assessment of antimalarial drug efficacy.
per: White, N
Publicat: (2002)

Clinical pharmacokinetics of antimalarial drugs.
per: White, N
Publicat: (1985)

The threat of antimalarial drug resistance
per: Hanboonkunupakarn, B, et al.
Publicat: (2016)

Retinal toxicity induced by antimalarial drugs: literature review and case report
per: Manuel Garza-Leon, et al.
Publicat: (2016-06-01)

Antimalarial drug resistance: the pace quickens.
per: White, N
Publicat: (1992)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
per: Barnes, K, et al.
Publicat: (2005)

Mode of action and features of antimalarial drugs
per: Nosten, F, et al.
Publicat: (1999)

Mode of action and features of antimalarial drugs.
per: Nosten, F, et al.
Publicat: (1999)

How do patients use antimalarial drugs? A review of the evidence.
per: Yeung, S, et al.
Publicat: (2005)

Delaying antimalarial drug resistance with combination chemotherapy.
per: White, N
Publicat: (1999)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
per: White, N
Publicat: (1997)

Preventing antimalarial drug resistance through combinations.
per: White, N
Publicat: (1998)

Antimalarial dosing regimens and drug resistance.
per: Barnes, K, et al.
Publicat: (2008)

The assessment of antimalarial drug efficacy in vivo
per: White, NJ
Publicat: (2022)

Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
per: Farrell DF
Publicat: (2012-03-01)

Why is it that antimalarial drug treatments do not always work?
per: White, N
Publicat: (1998)

Antimalarial drugs in pregnancy: a review.
per: Nosten, F, et al.
Publicat: (2006)

Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.
per: Phillips, R, et al.
Publicat: (1986)

Monitoring antimalarial drug efficacy - Reply
per: Mayxay, M, et al.
Publicat: (2004)

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
per: Stepniewska, K, et al.
Publicat: (2008)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
per: Price, R, et al.
Publicat: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
per: Price, R, et al.
Publicat: (2007)

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
per: Haeusler, I, et al.
Publicat: (2018)

How antimalarial drug resistance affects post-treatment prophylaxis.
per: White, N
Publicat: (2008)

Antimalarial mass drug administration: ethical considerations
per: Cheah, PY, et al.
Publicat: (2016)

Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs.
per: Supanaranond, W, et al.
Publicat: (1993)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
per: Olliaro Piero, et al.
Publicat: (2007-09-01)

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
per: Pukrittayakamee, S, et al.
Publicat: (2004)

A systematic overview of published antimalarial drug trials.
per: Myint, H, et al.
Publicat: (2004)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
per: Chairat, K, et al.
Publicat: (2018)

Does antimalarial mass drug administration increase or decrease the risk of resistance?
per: White, N
Publicat: (2016)

Effectiveness of antimalarial drugs.
per: Baird, J
Publicat: (2005)

Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.
per: Chotivanich, K, et al.
Publicat: (2009)

Therapeutic responses to different antimalarial drugs in vivax malaria.
per: Pukrittayakamee, S, et al.
Publicat: (2000)

Review of Atypical Organometallic Compounds as Antimalarial Drugs
per: Samuel K. Kwofie, et al.
Publicat: (2020-01-01)